Additionally, PlexusDx Precision Peptide Genetic Test can identify whether your genetic variants in GIPR, GLP1R, or MC4R pathways predispose you to heightened GLP-1 side effects, allowing your provider to adjust your starting dose and monitoring plan accordingly
I didn't do this and opted to forge ahead regardless of the cost
The treatment also decreased pro-inflammatory and pro-fibrotic gene expression with reduced macrophage infiltration (Li et al., 2025)
BPC-157 is not currently approved by the Therapeutic Goods Administration (TGA) for any therapeutic use in Australia
Ivanova, O.S., Levagina, G.M., Skarnovich, M.O., Skarnovich, M.A., Shishkina, L.N., Gamalei, S.G., and Danilenko, E.D., Preparation and characterization of double-stranded RNA from the yeast Saccharomyces cerevisiae for intranasal administration, Biofarm
Figure 2, A and B)